ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ABDX Abingdon Health Plc

11.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Abingdon Health Plc LSE:ABDX London Ordinary Share GB00BLF79J41 ORD 0.025P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 11.00 10.50 11.50 11.00 11.00 11.00 44,978 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Chemicals & Chem Preps, Nec 4.05M -3.45M -0.0284 -3.87 13.39M
Abingdon Health Plc is listed in the Chemicals & Chem Preps sector of the London Stock Exchange with ticker ABDX. The last closing price for Abingdon Health was 11p. Over the last year, Abingdon Health shares have traded in a share price range of 6.75p to 18.00p.

Abingdon Health currently has 121,716,822 shares in issue. The market capitalisation of Abingdon Health is £13.39 million. Abingdon Health has a price to earnings ratio (PE ratio) of -3.87.

Abingdon Health Share Discussion Threads

Showing 26 to 48 of 1650 messages
Chat Pages: Latest  6  5  4  3  2  1
DateSubjectAuthorDiscuss
08/2/2021
11:50
>>>hammopj

The Mail article states

"In December 2019, Abingdon Health was teetering on the brink, with losses of £1.5million. According to its last published accounts, the firm's directors were warning that to survive, it would have to cut costs and seek new investment."

They presumably came to this sensationalist conclusion after studying the company accounts (dated December 2019), hence my comment that I found the going concern statement in the accounts, unremarkable.

The Daily Mail may well wish to side with Good Law Project againt HMG on the supply of PPE and diagnostics, but it is a total irrelevance to link this to Abingdon Health's prospects as of December 2019 (which pre-dates any discussions on COVID related PPE and diagnostics)

timbo003
08/2/2021
11:21
It's unremarkable because the contract cancellation was omitted!
hammopj
08/2/2021
10:57
These must be worth buying at this level with news to come.
grosstonnage
08/2/2021
08:57
There are no limits to the corruption surrounding this govts handing of COVID
pomp circumstance
08/2/2021
08:07
The going concern statement in the 2019 accounts looks unremarkable to me, fairly standard stuff for a rapidly growing high tech SME which is going to require further growh capital in order to execute their business plan
timbo003
08/2/2021
07:35
This appears to be the Daily Mail article referred to in today's RNS
timbo003
02/2/2021
22:40
We are hosting a webinar with Abingdon Health on the 10th Feb which may be of interest to current investors and potential shareholders:
sharesoc
29/1/2021
08:52
https://www.med-technews.com/
chrisdr2
29/1/2021
08:14
Can you explain how the government is invested and details of the cpnsortium members? I cannot seem to find info. Thanks
hammopj
28/1/2021
15:31
They're not going after the UK companies. It's GLP v Secretary of State for Health and Social Care. I feel sure the consortium members knew the government had a financial interest in the contract when they got into bed with it.
mr macgregor
28/1/2021
15:24
Good law project would rather go after uk companies rather than go after the government for their purchasing of the innova tests or the 7k per day consultation fees being charged for test and trace Something stinks
jock3636
28/1/2021
15:20
Well the government awarded a valuable contract to Abingdon's consortium without competitive tender. What seems worse to me is that the government was invested in Abingdon so stood to gain financially from the contract it awarded. That conflict of interest looks like corruption. Since the contract was awarded the values of the companies in the consortium have multiplied. The case is going to court which isn't good for the reputations of the companies involved. This, along with the fact that Abingdon's consortium didn't receive MHRA approval from the UK, at a time when the government desperately wants to promote UK companies and home brew diagnostic tests, presumably won't help the mooted international sales drive.
mr macgregor
28/1/2021
11:23
Why the pannic?? Gov't simply switching to a more competitive purchasing platform as they are under increasing scrutiny. Numbers for H2 stated at c£7.7m v £1.5m H1. On target to obtain accreditation in 27 other countries too. They have other non Covid-19 products too. Investors, dont throw the baby out with the bathwater!!
chrisdr2
27/1/2021
21:45
Here's a date for your diaries:




You will need to register but it is a painless process (and free) 🙂

timbo003
27/1/2021
21:24
Note clarification released by the company at 18:13 this evening:
timbo003
27/1/2021
15:57
The aint going to not place massive orders to placate a few looney liberals.

Send em all to Venezuela

hodhasharon
27/1/2021
14:03
Ie. Covering its back - doesn't seem to have affect the sp
janhar
27/1/2021
14:02
Is it possible the government is trying to prove that it wasn't handing out contracts to preferred suppliers rather than going through the correct channels?
janhar
27/1/2021
13:55
No wonder they suddenly rushed to market, there's some odd stuff going on here!
pomp circumstance
27/1/2021
13:53
GET OUT NOW
pomp circumstance
26/1/2021
08:49
hxxps://www.bmj.com/content/371/bmj.m4262

G.

garth
26/1/2021
08:29
This could be something big when more people catch on to it..Antigen testing very much needed this year if we want normality
allstars001
06/1/2021
09:49
London’s AIM market had a remarkable 2020, ending the year with its market value at an all-time high, with the AIM index also significantly outperforming other UK main market indices.

Investor’s Champion’s monthly update covers all the newcomers from December, including Abingdon Health, and comments on an eventful year for London’s growth market which had a record 24 companies valued at more than £1billion each at the year end.

energeticbacker
Chat Pages: Latest  6  5  4  3  2  1

Your Recent History

Delayed Upgrade Clock